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A NEW CASE OF (TA)8 ALLELE IN THE UGT1A1 GENE PROMOTER
IN A CAUCASIAN GIRL WITH GILBERT SYNDROME
Henrique Coelho and Elı´sio Costa  Servic¸o de Hematologia, Hospital de
Crianc¸as Maria Pia, Porto, Portugal
Emı´lia Vieira  Unidade de Gene´tica Molecular do Instituto de Gene´tica
Me´dica, Dr. Jacinto de Magalha˜es, Porto, Portugal
Rosa Branca  Servic¸o de Hematologia, Hospital de Crianc¸as Maria Pia, Porto,
Portugal
Rosa´rio dos Santos  Unidade de Gene´tica Molecular do Instituto de Gene´tica
Me´dica, Dr. Jacinto de Magalha˜es, Porto, Portugal
Jose´ Barbot  Servic¸o de Hematologia, Hospital de Crianc¸as Maria Pia, Porto,
Portugal
 The authors describe a 5-year-old Caucasian girl, referred to their hospital for evaluation of an
unconjugated hyperbilirubinemia (57.9 µmol/L) detected from blood analysis during an episode of
fever. The molecular analysis of the TATA-box region of the UGT1A1 gene revealed that the patient
was a compound heterozygote for two insertions, one TA and the other TATA [(TA)7/(TA)8]. This
is the first case of (TA)8 allele found in a Portuguese Caucasian patient and the third found in the
literature.
Keywords. bilirubin, Gilbert syndrome, hyperbilirubinemia, UGT1A1
Gilbert syndrome (GS) is characterized by a chronic, nonhemolytic
unconjugated hyperbilirubinemia in the absence of liver disease or overt
hemolysis. On the basis of serum bilirubin levels, 3–10% of the general pop-
ulation are estimated to have GS. Serum bilirubin levels vary according to
time, intercurrent illness, or fasting [1–4].
Hepatic glucuronization of bilirubin is catalyzed by isoenzyme 1A1 of
UDP-glucuronosyltransferase (UGT1A1). The first mutation in this gene was
described in 1992 [5]. It was a nonsense mutation found in homozygosity in
a patient with Criegler–Najar syndrome (CNS) [6]. Only in 1995 were muta-
tions in this gene found to be correlated with GS [2]. To date, more than 50
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mutations causing GS or CNS have been described. However, the main cause
of GS in all studied populations is a TA insertion in the repetitive TATA box
of the gene promoter, which normally consists of 6 repeats. This (TA)7 al-
lele is extremely common, occurring with a frequency of 38% in Caucasians
[1–3, 5]. This TATA-box region is the binding site for the transcription fac-
tor IID, and for this reason plays an important role in the initiation of the
transcription [2]. A variation in this sequence results in a reduction of the
efficiency and accuracy of gene expression leading to higher bilirubin levels
[2, 7].
The authors report on a Caucasian girl with GS, who was found to be a
compound heterozygote for the (TA)7 and (TA)8 alleles.
CASE REPORT
In November 2002, a 5-year-old girl was referred to our hospital for eval-
uation of an unconjugated hyperbilirubinemia detected by blood analysis
during an episode of fever. The girl had been born of a full-term pregnancy
and had a clinical history of prolonged neonatal jaundice (5 weeks) consid-
ered a result of breast feeding. Neither sclera icterus nor liver or spleen en-
largement was observed on clinical examination. The laboratory evaluation
revealed a low-grade unconjugated hyperbilirubinemia (57.9 µmol/L), nor-
mal routine tests of liver function, and no overt hemolysis. The father and
mother have normal bilirubin levels (14.2 and 9.4 µmol/L, respectively).
Molecular analysis of the TATA-box region of the UGT1A1 gene was per-
formed by fluorescence-labeled polymerase chain reaction using the primers
described by Bancroft et al. [8] and the conditions previously described
[9, 10]. The analysis revealed that our patient was a compound heterozygote
for two insertions, one TA and the other TATA [(TA)7/(TA)8] (Figure 1).
The father was heterozygote for the TATA insersion [(TA)6/(TA)8] and the
mother for the TA ones [(TA)6/(TA)7].
DISCUSSION
Traditionally, GS has been a diagnosis of exclusion. Routine biochem-
istry measurement of enzymatic activity has never been possible but genetic
testing for GS has the potential to provide a positive diagnosis.
To date, we have studied the promoter region of the UGT1A1 gene in
60 patients referred to our center with clinical diagnosis of GS. Fifty-two
were found to be homozygotes, 7 were heterozygotes for the (TA)7 allele,
and only the case described here has the (TA)8 allele. In fact, no other
Portuguese patients were described as having the present mutation. In the
literature, only 2 further cases of (TA)8 allele have been described in Cau-
casian patients. The first [7] was a girl from Taranto (Apulia), Italy, with
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FIGURE 1 Screening for UGT1A1 promoter variants, performed by fluorescence-labeled PCR. The am-
plified DNA fragments were separated by automated capillary electrophoresis and analyzed with ABI
GeneScan program (Applied Biosystems). (A) Homozygosity for the normal (TA)6 allele; (B) homozy-
gosity for a mutant (TA)7 allele; (C) our patient with (TA)7 and (TA)8 alleles.
the presence of the same compound heterozygosity. Besides the similarity in
terms of age and gender, this case presented a bilirubin level of 60 µmol/L,
comparable to that found in our case. Taken together, these cases provide ev-
idence toward a correlation between phenotype and genotype. The second
case [11] was a 3-year-old boy from Greece who was found to be heterozy-
gous for the (TA)6 allele [(TA)6/(TA)8].
In Caucasian populations the (TA)8 allele is extremely rare [6, 7]. How-
ever, in African populations this allele is more common, with a frequency
of 6.9%. The presence of this rare allele in the Caucasian population was
suggested by Iolascon et al. [7] and Tsezou et al. [11] to be a result of a re-
cent genetic event and not derived from a common ancestral mutation. In
effect, repeated sequences are extremely unstable and may be lengthened
or shortened by a variety of mechanisms, such as unequal crossing over in
meiosis.
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